A standardized measure for 9‐tetrahydrocannabinol (THC) content in cannabis products is necessary to advance research both on the adverse effects of cannabis (e.g. risks for brain development, mental illness and addiction) and on the drug's potential medical uses.
Although cannabis use disorder (CUD) is one of the most common substance use disorders (SUDs), the impact of CUD on the brain remains unclear and understudied.
In a recent article, published in Addiction journal, researchers from the University of Amsterdam and Ludwig Maximilan University have brought together the existing research on the relationship between heavy cannabis use, cannabis use disorder (CUD) and the brain.
Cannabis is one of the most widely used psychoactive substances in Canada.
The complex relationship between cannabis use and mental disorders has garnered significant attention as a public health issue
This is the first in a series of reports, published by the Canadian Centre on Substance Use and Addiction (CCSA), that reviews the effects of cannabis use on various aspects of human functioning and development.
Prevention Plus Wellness (PPW) provides easy to use evidence-informed resources to help prevention and health specialists and parents prevent youth and young adult alcohol, cannabis, tobacco, e-cigarette, and opioid use while promoting protective wellness lifestyles.
Rapid Increase in the Prevalence of Cannabis Use Among People with Depression in the United States, 2005–17: The Role of Differentially Changing Risk Perceptions
To estimate trends in the prevalence of cannabis use and risk perceptions of cannabis use from 2005 to 2017 among United States people with and without depression.
Wednesday, October 28, 2020 @ 3-4:00pm ET (2CT/1MT/12PT)
Hailed as safe, natural and a potential cure-all by the public, both medical and recreational cannabis is quickly becoming legal and mainstream across the country. While it has the potential to help fill state coffers, there are many unintended consequences that will mean big challenges for addiction specialists.
There has been increased interest in the role of cannabis for treating medical conditions. The availability of different cannabis-based products can make the side effects of exposure unpredictable. We sought to conduct a scoping review of systematic reviews assessing benefits and harms of cannabis-based medicines for any condition.
Delta 9‐tetrahydrocannabinol - a psychoactive compound found in cannabis - activates parts of the brain responsible for cognition, perception, anxiety, fear, memory and reward.
There are continuous debates about the link between cannabis use and psychotic disorders.
The 4th Annual Scientific Meeting of the Research Society on Marijuana (RSMj) will be held from July 24-26, 2020 in Boston, MA.